BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21289174)

  • 1. Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability.
    Valor LM; Pulopulos MM; Jimenez-Minchan M; Olivares R; Lutz B; Barco A
    J Neurosci; 2011 Feb; 31(5):1652-63. PubMed ID: 21289174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CREB binding protein is required for both short-term and long-term memory formation.
    Chen G; Zou X; Watanabe H; van Deursen JM; Shen J
    J Neurosci; 2010 Sep; 30(39):13066-77. PubMed ID: 20881124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive CREB-DNA interactions at gene loci predetermined by CBP induce activity-dependent gene expression in human cortical neurons.
    Atsumi Y; Iwata R; Kimura H; Vanderhaeghen P; Yamamoto N; Sugo N
    Cell Rep; 2024 Jan; 43(1):113576. PubMed ID: 38128530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction.
    Hallam TM; Bourtchouladze R
    Cell Mol Life Sci; 2006 Aug; 63(15):1725-35. PubMed ID: 16786226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder.
    de Thonel A; Ahlskog JK; Daupin K; Dubreuil V; Berthelet J; Chaput C; Pires G; Leonetti C; Abane R; Barris LC; Leray I; Aalto AL; Naceri S; Cordonnier M; Benasolo C; Sanial M; Duchateau A; Vihervaara A; Puustinen MC; Miozzo F; Fergelot P; Lebigot É; Verloes A; Gressens P; Lacombe D; Gobbo J; Garrido C; Westerheide SD; David L; Petitjean M; Taboureau O; Rodrigues-Lima F; Passemard S; Sabéran-Djoneidi D; Nguyen L; Lancaster M; Sistonen L; Mezger V
    Nat Commun; 2022 Nov; 13(1):7002. PubMed ID: 36385105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update and Potential Opportunities in CBP [Cyclic Adenosine Monophosphate (cAMP) Response Element-Binding Protein (CREB)-Binding Protein] Research Using Computational Techniques.
    Akinsiku OE; Soremekun OS; Soliman MES
    Protein J; 2021 Feb; 40(1):19-27. PubMed ID: 33394237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Kdm5c Causes Spurious Transcription and Prevents the Fine-Tuning of Activity-Regulated Enhancers in Neurons.
    Scandaglia M; Lopez-Atalaya JP; Medrano-Fernandez A; Lopez-Cascales MT; Del Blanco B; Lipinski M; Benito E; Olivares R; Iwase S; Shi Y; Barco A
    Cell Rep; 2017 Oct; 21(1):47-59. PubMed ID: 28978483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing histone acetylation improves sociability and restores learning and memory in KAT6B-haploinsufficient mice.
    Bergamasco MI; Vanyai HK; Garnham AL; Geoghegan ND; Vogel AP; Eccles S; Rogers KL; Smyth GK; Blewitt ME; Hannan AJ; Thomas T; Voss AK
    J Clin Invest; 2024 Apr; 134(7):. PubMed ID: 38557491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Histone H2B Acetylation Modification in Aluminum-Induced Cognitive Dysfunction.
    Gao J; Liu W; Pei J; Li J; Hao N; Yang S; Yang X; Zou D; Xu K; Zhang L
    Biol Trace Elem Res; 2024 Aug; 202(8):3731-3739. PubMed ID: 37979070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATAT1 regulates forebrain development and stress-induced tubulin hyperacetylation.
    Li L; Jayabal S; Ghorbani M; Legault LM; McGraw S; Watt AJ; Yang XJ
    Cell Mol Life Sci; 2019 Sep; 76(18):3621-3640. PubMed ID: 30953095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enriched environment enhances histone acetylation of NMDA receptor in the hippocampus and improves cognitive dysfunction in aged mice.
    Wang X; Meng ZX; Chen YZ; Li YP; Zhou HY; Yang M; Zhao TT; Gong YL; Wu Y; Liu T
    Neural Regen Res; 2020 Dec; 15(12):2327-2334. PubMed ID: 32594057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement.
    Lopez-Atalaya JP; Ciccarelli A; Viosca J; Valor LM; Jimenez-Minchan M; Canals S; Giustetto M; Barco A
    EMBO J; 2011 Aug; 30(20):4287-98. PubMed ID: 21847097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic factors in intellectual disability: the Rubinstein-Taybi syndrome as a paradigm of neurodevelopmental disorder with epigenetic origin.
    Lopez-Atalaya JP; Valor LM; Barco A
    Prog Mol Biol Transl Sci; 2014; 128():139-76. PubMed ID: 25410544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking miRNA Biogenesis in Adult Forebrain Neurons Enhances Seizure Susceptibility, Fear Memory, and Food Intake by Increasing Neuronal Responsiveness.
    Fiorenza A; Lopez-Atalaya JP; Rovira V; Scandaglia M; Geijo-Barrientos E; Barco A
    Cereb Cortex; 2016 Apr; 26(4):1619-1633. PubMed ID: 25595182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition.
    Lopez-Atalaya JP; Ito S; Valor LM; Benito E; Barco A
    Nucleic Acids Res; 2013 Sep; 41(17):8072-84. PubMed ID: 23821663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is histone acetylation the most important physiological function for CBP and p300?
    Bedford DC; Brindle PK
    Aging (Albany NY); 2012 Apr; 4(4):247-55. PubMed ID: 22511639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders.
    Valor LM; Viosca J; Lopez-Atalaya JP; Barco A
    Curr Pharm Des; 2013; 19(28):5051-64. PubMed ID: 23448461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of histone acetylation in memory formation and cognitive impairments.
    Peixoto L; Abel T
    Neuropsychopharmacology; 2013 Jan; 38(1):62-76. PubMed ID: 22669172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal focal knockout of CBP affects specific histone modifications, long-term potentiation, and long-term memory.
    Barrett RM; Malvaez M; Kramar E; Matheos DP; Arrizon A; Cabrera SM; Lynch G; Greene RW; Wood MA
    Neuropsychopharmacology; 2011 Jul; 36(8):1545-56. PubMed ID: 21508930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement.
    Lacombe D; Bloch-Zupan A; Bredrup C; Cooper EB; Houge SD; García-Miñaúr S; Kayserili H; Larizza L; Lopez Gonzalez V; Menke LA; Milani D; Saettini F; Stevens CA; Tooke L; Van der Zee JA; Van Genderen MM; Van-Gils J; Waite J; Adrien JL; Bartsch O; Bitoun P; Bouts AHM; Cueto-González AM; Dominguez-Garrido E; Duijkers FA; Fergelot P; Halstead E; Huisman SA; Meossi C; Mullins J; Nikkel SM; Oliver C; Prada E; Rei A; Riddle I; Rodriguez-Fonseca C; Rodríguez Pena R; Russell J; Saba A; Santos-Simarro F; Simpson BN; Smith DF; Stevens MF; Szakszon K; Taupiac E; Totaro N; Valenzuena Palafoll I; Van Der Kaay DCM; Van Wijk MP; Vyshka K; Wiley S; Hennekam RC
    J Med Genet; 2024 May; 61(6):503-519. PubMed ID: 38471765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.